Terms: = Endocrine gland cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
604 results:
1. Genetic Signature of Human Pancreatic cancer and Personalized Targeting.
Reshkin SJ; Cardone RA; Koltai T
Cells; 2024 Mar; 13(7):. PubMed ID: 38607041
[TBL] [Abstract] [Full Text] [Related]
2. Twelve-month progression-free survival with sotorasib and panitumumab in kras G12C mutant metastatic colorectal cancer.
Kavgaci G; Dizdar O; Yalcin S
Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
[TBL] [Abstract] [Full Text] [Related]
3. [Stratified application of gene expression in diagnosis of thyroid nodules].
Guan WY; Zheng JY; Nie L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
[No Abstract] [Full Text] [Related]
4.
Sfreddo HJ; Koh ES; Zhao K; Swartzwelder CE; Untch BR; Marti JL; Roman BR; Dublin J; Wang RS; Xia R; Cohen JM; Xu B; Ghossein R; Givi B; Boyle JO; Tuttle RM; Fagin JA; Wong RJ; Morris LGT
Thyroid; 2024 Apr; 34(4):450-459. PubMed ID: 38407967
[No Abstract] [Full Text] [Related]
5. Droplet digital polymerase chain reaction detection of kras mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation.
Mansour Y; Boubaddi M; Odion T; Marty M; Belleannée G; Berger A; Subtil C; Laurent C; Dabernat S; Amintas S
Cancer Cytopathol; 2024 May; 132(5):274-284. PubMed ID: 38308613
[TBL] [Abstract] [Full Text] [Related]
6. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
7. Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review.
Kwan MC; Pitman MB; Fernandez-Del Castillo C; Zhang ML
Gut; 2024 Mar; 73(4):629-638. PubMed ID: 38195219
[TBL] [Abstract] [Full Text] [Related]
8. [Histopathologic diagnosis of solid and cystic pancreatic lesions with a focus on ductal adenocarcinoma : A vademecum for daily practice].
Esposito I; Yavas A; Häberle L
Pathologie (Heidelb); 2024 Feb; 45(1):5-18. PubMed ID: 38191761
[TBL] [Abstract] [Full Text] [Related]
9. Mass spectrometry analysis of intact protein
Xu M; Liu Z; Hu W; Han Y; Wu Z; Chen S; Xia P; DU J; Zhang X; Hao P; Xia J; Yang S
J Zhejiang Univ Sci B; 2024 Jan; 25(1):51-64. PubMed ID: 38163666
[TBL] [Abstract] [Full Text] [Related]
10. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma.
Debernardi S; Liszka L; Ntala C; Steiger K; Esposito I; Carlotti E; Baker AM; McDonald S; Graham T; Dmitrovic B; Feakins RM; Crnogorac-Jurcevic T
Mol Oncol; 2024 Mar; 18(3):677-690. PubMed ID: 38145461
[TBL] [Abstract] [Full Text] [Related]
11. Precision medicine for kras wild-type pancreatic adenocarcinomas.
Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
[TBL] [Abstract] [Full Text] [Related]
13. K-ras gene mutation analysis to diagnosis pancreatic adenocarcinoma from endoscopic ultrasound-guided tissue acquisition; a systematic review and meta-analysis.
Tamura T; Ashida R; Wan K; Shimokawa T; Kitano M
Pancreatology; 2024 Feb; 24(1):78-87. PubMed ID: 38042675
[TBL] [Abstract] [Full Text] [Related]
14. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
15. Fine-needle biopsy of thyroid nodules and the contribution of molecular analysis of BRAF and RAS mutations.
Kasko M; Grigerova M; Alemayehu A; Zavodna K; Kasko V; Podoba J
Bratisl Lek Listy; 2023; 124(12):869-872. PubMed ID: 37983279
[TBL] [Abstract] [Full Text] [Related]
16. Clinical and genomic characterisation of early-onset pancreatic cancer.
Castet F; Fabregat-Franco C; Castillo G; Navarro V; Sierra A; Acosta DA; López-Valbuena D; Dienstmann R; Tabernero J; Vivancos A; Tian TV; Macarulla T
Eur J Cancer; 2023 Nov; 194():113338. PubMed ID: 37793216
[TBL] [Abstract] [Full Text] [Related]
17. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
18. Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in Pancreatic cancer.
Sellahewa R; Moghaddam SM; Lundy J; Jenkins BJ; Croagh D
Pancreas; 2023 Mar; 52(3):e188-e195. PubMed ID: 37751379
[TBL] [Abstract] [Full Text] [Related]
19. Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification.
Zhou Y; Wu X; Zhang Y; Li Z; Ge X; Chen H; Mao Y; Ding W
PeerJ; 2023; 11():e16054. PubMed ID: 37744220
[TBL] [Abstract] [Full Text] [Related]
20. Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic cancer.
Levink IJM; Jansen MPHM; Azmani Z; van IJcken W; van Marion R; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685923
[TBL] [Abstract] [Full Text] [Related]
[Next]
